Explain this page
Arphra AIPlain-English read on PTC Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +79.46% | +80.04% | +78.97% | +80.65% | +83.76% | +82.70% | +83.42% | +81.08% |
| Operating margin | +21.07% | +23.14% | +21.86% | +25.58% | +35.86% | +27.96% | +28.21% | +27.46% |
| EBITDA margin | +31.25% | +29.66% | +28.57% | +31.76% | +41.35% | +32.94% | +34.84% | +33.03% |
| EBIT margin | +24.47% | +23.35% | +22.03% | +25.61% | +36.40% | +28.39% | +27.78% | +28.45% |
| Pre-tax margin | +21.68% | +20.54% | +15.86% | +20.40% | +33.59% | +23.58% | +22.77% | +22.66% |
| Net margin | +26.39% | +16.19% | +11.71% | +16.37% | +26.80% | +18.67% | +18.30% | +18.27% |
| Cost structure | ||||||||
| Cost of revenue / sales | +20.54% | +19.96% | +21.03% | +19.35% | +16.24% | +19.44% | +18.78% | +18.76% |
| R&D intensity | +16.60% | +17.53% | +18.81% | +18.84% | +16.71% | +17.98% | +18.40% | +18.64% |
| SG&A intensity | +40.05% | +35.69% | +36.41% | +34.43% | +28.93% | +32.46% | +34.14% | +32.61% |
| Effective tax rate | -21.74% | +21.16% | +26.17% | +19.75% | +20.23% | +21.99% | +22.14% | +23.08% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +23.40% | +13.64% | +9.17% | +11.71% | +19.18% | +13.35% | +13.41% | +13.61% |
| Return on assets (ROA) | +10.58% | +6.68% | +3.90% | +5.90% | +11.09% | +7.00% | +6.60% | +6.83% |
| Return on capital (ROC) | +10.33% | +11.66% | +10.04% | +11.43% | +18.91% | +13.09% | +13.41% | +13.18% |
| Return on invested capital (ROIC) | +12.94% | +8.16% | +5.38% | +7.31% | +14.13% | +8.74% | +8.70% | +8.77% |
| Asset turnover | +40.09% | +41.25% | +33.35% | +36.01% | +41.40% | +37.48% | +36.04% | +37.39% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +26.39% | +16.19% | +11.71% | +16.37% | +26.80% | +18.67% | +18.30% | +18.27% |
| Asset turnover (× revenue / assets) | +40.09% | +41.25% | +33.35% | +36.01% | +41.40% | +37.48% | +36.04% | +37.39% |
| Equity multiplier (× assets / equity) | +221.12% | +204.15% | +234.90% | +198.59% | +172.94% | +190.69% | +203.35% | +199.27% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.40 | 0.41 | 0.33 | 0.36 | 0.41 | 0.37 | 0.36 | 0.37 |
| Fixed-asset turnover | 7.15 | 8.20 | 9.06 | 11.02 | 15.58 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 3.34 | 3.04 | 2.58 | 2.67 | 2.74 | — | — | — |
| Payables turnover | 11.12 | 9.61 | 10.14 | 18.38 | 38.68 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 109.28 | 120.18 | 141.23 | 136.88 | 133.39 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 32.83 | 37.97 | 35.99 | 19.86 | 9.44 | — | — | — |
| Cash conversion cycle | 76.45 | 82.21 | 105.24 | 117.02 | 123.96 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 0.77 | 1.39 | 2.49 | 1.99 | 1.18 | 1.71 | 1.72 | 1.70 |
| FCF / Net income | 0.72 | 1.31 | 2.39 | 1.94 | 1.17 | 1.58 | 1.69 | 1.68 |
| FCF margin | +19.01% | +21.17% | +27.96% | +31.83% | +31.27% | +29.56% | +30.87% | +30.61% |
| OCF margin | +20.41% | +22.52% | +29.13% | +32.63% | +31.68% | +31.84% | +31.39% | +31.12% |
| CapEx / Revenue | +1.40% | +1.34% | +1.17% | +0.80% | +0.40% | +0.80% | +0.78% | +0.79% |
| CapEx / D&A | 0.21 | 0.21 | 0.18 | 0.13 | 0.08 | — | — | — |
| Stock-based comp / Revenue | +9.81% | +9.04% | +9.85% | +9.72% | +7.89% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 4.03 | 2.65 | 2.06 | 3.12 | 6.08 | 7.99 | 8.61 | 9.68 |
| EPS · basic | 4.08 | 2.67 | 2.07 | 3.14 | 6.12 | 8.15 | 8.63 | 9.78 |
| Book value / share | 17.22 | 19.42 | 22.44 | 26.62 | 31.68 | 31.40 | 32.34 | 34.20 |
| Tangible BV / share | -4.50 | -3.72 | -13.60 | -9.48 | -4.07 | 31.40 | 32.34 | 34.20 |
| Sales / share | 15.27 | 16.35 | 17.57 | 19.04 | 22.68 | 22.44 | 23.70 | 25.48 |
| Operating CF / share | 3.12 | 3.68 | 5.12 | 6.21 | 7.18 | 7.14 | 7.44 | 7.93 |
| Free cash flow / share | 2.90 | 3.46 | 4.91 | 6.06 | 7.09 | 6.63 | 7.32 | 7.80 |
| Dividends / share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retention ratio | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +6.98% | +8.47% | +9.60% | +19.18% | -0.62% | +5.90% | +7.46% | +8.01% |
| Gross profit · YoY | — | +7.75% | +7.02% | +11.93% | +23.77% | -1.87% | +6.83% | +4.44% | +8.32% |
| Profit | |||||||||
| Operating income · YoY | — | +17.50% | +2.48% | +28.27% | +67.05% | -22.51% | +6.84% | +4.58% | +12.17% |
| EBITDA · YoY | — | +1.53% | +4.49% | +21.84% | +55.15% | -20.83% | +12.01% | +1.89% | +8.86% |
| Net income · YoY | — | -34.35% | -21.57% | +53.27% | +95.04% | -30.75% | +3.80% | +7.27% | +2.48% |
| Operating | |||||||||
| EBIT · YoY | — | +2.07% | +2.35% | +27.41% | +69.41% | -22.49% | +3.63% | +10.04% | +10.35% |
| R&D · YoY | — | +12.97% | +16.39% | +9.81% | +5.69% | +6.95% | +8.40% | +8.83% | +9.81% |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -34.24% | -22.26% | +51.46% | +94.87% | +31.38% | +7.78% | +12.43% | +13.33% |
| EPS · basic · YoY | — | -34.56% | -22.47% | +51.69% | +94.90% | +33.19% | +5.91% | +13.31% | +13.31% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $1.65B | $1.54B | $1.89B | $1.93B | $1.37B | $2.01B | $2.13B | $2.3B |
| Net debt | $1.32B | $1.27B | $1.6B | $1.66B | $1.19B | $1.71B | $1.82B | $1.96B |
| Net debt / EBITDA | 2.34 | 2.21 | 2.67 | 2.28 | 1.05 | 1.90 | 1.82 | 1.92 |
| Debt / equity | 0.81 | 0.67 | 0.71 | 0.60 | 0.36 | 0.53 | 0.54 | 0.55 |
| Debt / assets | +36.57% | +32.86% | +30.04% | +30.24% | +20.70% | +27.61% | +26.65% | +27.73% |
| Equity / assets | +45.22% | +48.98% | +42.57% | +50.35% | +57.82% | +52.44% | +49.18% | +50.18% |
| Coverage | ||||||||
| EBITDA / interest expense | 11.19 | 10.57 | 4.63 | 6.10 | 14.71 | 6.80 | 7.20 | 6.95 |
| Operating income / interest | 7.54 | 8.24 | 3.54 | 4.91 | 12.76 | 5.77 | 5.83 | 5.78 |
| Interest expense | $50.48M | $54.27M | $129.42M | $119.65M | $77.02M | $131.85M | $139.47M | $147.21M |
| Liquidity | ||||||||
| Current ratio | 1.38 | 1.35 | 0.76 | 0.78 | 1.12 | — | — | — |
| Quick ratio | 1.11 | 1.15 | 0.66 | 0.68 | 0.96 | — | — | — |
| Cash ratio | 0.42 | 0.34 | 0.17 | 0.16 | 0.15 | — | — | — |
| Working capital | $293.73M | $276.4M | -$393.82M | -$368.49M | $145.96M | — | — | — |
| Working capital / revenue | +16.25% | +14.30% | -18.78% | -16.03% | +5.33% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).